Update: FDA Approves Ultomiris for NMOSD
London, UK — AstraZenca Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor…
Update: TotalEnergies Triumphs in French Rooftop Solar Tender
TotalEnergies ranks first in the latest call for tenders issued by the French Energy Regulatory Commission (CRE), winning more than 80 MWp or…
Update: Wienerberger Posts Positive Results in 2023, Acquires Terreal and Creaton
Wienerberger had a successful business year in 2023 despite economic challenges, with revenues of €4.2 billion and operating EBITDA of €811 million.
Update: Airbus Bolsters Cybersecurity with Infodas Acquisition
Airbus is acquiring INFODAS, a German cybersecurity company, to enhance its cybersecurity offerings for defense and critical infrastructure sectors.
Mont Cervin SARL Now Owns More Than 3% of Ontex Group
Ontex Group NV disclosed a notification of significant shareholdings received on March 21, 2024.
Danone Lost €1.2 Billion in Russia
Danone sent out a press release about its EDP business in Russia, providing updates.
Novartis Receives Positive CHMP Opinion for Fabhalta PNH Therapy
Novartis receives positive CHMP opinion for Fabhalta® as first oral monotherapy for PNH in adults.
Personal Hygiene Solutions Maker Ontex “In The Top 10 of Belgian Patent Applicants”
Ontex is in the top 10 of Belgian patent applicants for the second year in a row, showcasing its commitment to innovation in…
UCB: Positive CHMP Opinion for Hidradenitis Suppurativa (HS) Treatment BIMZELX
UCB said Friday it received positive Committee for Medicinal Products for Human Use (CHMP) opinion for BIMZELX for treating moderate to severe hidradenitis…
Update: Givaudan SA’s 2024 AGM Confirms 1.5% Dividend Increase
Givaudan SA's 2024 Annual General Meeting on March 21st saw approval of all Board proposals, a 1.5% dividend increase for the 23rd year,…